Mayinglong Pharmaceutical Group Co Ltd Free Cash Flow Generation Index
Mayinglong Pharmaceutical Group Co Ltd free cash flow generation index. Mayinglong Pharmaceutical Group Co Ltd (600993) has a Free Cash Flow Generation Index of 1.10x as of September 2025. Free cash flow of CN¥152.93 Million represents 1% of operating cash flow (CN¥139.20 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Free cash flow generation index of Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2025. Historical FCF Generation Index trend for Mayinglong Pharmaceutical Group Co Ltd across 22 annual periods. See how financially flexible is Mayinglong Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
Mayinglong Pharmaceutical Group Co Ltd Free Cash Flow Generation Index by Year (2003–2025)
Mayinglong Pharmaceutical Group Co Ltd free cash flow generation index by year from 2003 to 2025. Year-by-year Free Cash Flow Generation Index for Mayinglong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600993 cash generation efficiency.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | CN¥481.07 Million | CN¥600.44 Million | CN¥119.37 Million | ▲ +35.7% |
| 2024 | 0.59x | CN¥293.76 Million | CN¥497.61 Million | CN¥203.85 Million | ▲ +0.3% |
| 2023 | 0.59x | CN¥355.70 Million | CN¥604.07 Million | CN¥248.36 Million | ▼ -24.6% |
| 2022 | 0.78x | CN¥266.84 Million | CN¥341.85 Million | CN¥75.01 Million | ▼ -12.4% |
| 2021 | 0.89x | CN¥532.07 Million | CN¥597.17 Million | CN¥65.10 Million | ▲ +6.1% |
| 2020 | 0.84x | CN¥237.58 Million | CN¥282.99 Million | CN¥45.41 Million | ▼ -7.3% |
| 2019 | 0.91x | CN¥445.23 Million | CN¥491.58 Million | CN¥46.36 Million | ▼ -1.4% |
| 2018 | 0.92x | CN¥283.28 Million | CN¥308.24 Million | CN¥24.96 Million | ▲ +4.2% |
| 2017 | 0.88x | CN¥314.26 Million | CN¥356.17 Million | CN¥41.91 Million | ▲ +21.2% |
| 2016 | 0.73x | CN¥174.36 Million | CN¥239.60 Million | CN¥65.24 Million | ▲ +125.8% |
| 2015 | 0.32x | CN¥58.92 Million | CN¥182.85 Million | CN¥123.93 Million | ▲ +649.9% |
| 2014 | 0.04x | CN¥4.80 Million | CN¥111.67 Million | CN¥106.87 Million | ▼ -87.9% |
| 2013 | 0.36x | CN¥46.26 Million | CN¥129.94 Million | CN¥83.68 Million | ▼ -55.9% |
| 2012 | 0.81x | CN¥136.50 Million | CN¥169.25 Million | CN¥32.75 Million | ▲ +98.2% |
| 2011 | 0.41x | CN¥30.67 Million | CN¥75.37 Million | CN¥44.69 Million | ▼ -51.5% |
| 2009 | 0.84x | CN¥181.18 Million | CN¥216.11 Million | CN¥34.93 Million | ▲ +23.3% |
| 2008 | 0.68x | CN¥69.75 Million | CN¥102.59 Million | CN¥32.84 Million | ▲ +124.3% |
| 2007 | -2.80x | CN¥-18.16 Million | CN¥6.49 Million | CN¥24.65 Million | ▼ -490.7% |
| 2006 | 0.72x | CN¥53.95 Million | CN¥75.27 Million | CN¥21.32 Million | ▲ +86.3% |
| 2005 | 0.38x | CN¥22.49 Million | CN¥58.43 Million | CN¥35.95 Million | ▼ -17.4% |
| 2004 | 0.47x | CN¥25.25 Million | CN¥54.19 Million | CN¥28.94 Million | ▼ -40.6% |
| 2003 | 0.78x | CN¥52.98 Million | CN¥67.52 Million | CN¥14.54 Million | — |